邢 艳,吴玉梅.局部晚期宫颈癌新辅助化疗研究进展[J].肿瘤学杂志,2014,20(12):967-971. |
局部晚期宫颈癌新辅助化疗研究进展 |
Progress in Neoadjuvant Chemotherapy in the Treatment for Locally Advanced Cervical Cancer |
投稿时间:2014-06-29 |
DOI:10.11735/j.issn.1671-170X.2014.12.B001 |
|
|
中文关键词: 宫颈肿瘤 新辅助化疗 介入化疗 疗效评价 |
英文关键词:cervical neoplasms neoadjuvant chemotherapy interventional chemotherapy efficacy evaluation |
基金项目: |
|
摘要点击次数: 1911 |
全文下载次数: 945 |
中文摘要: |
摘 要:宫颈癌发病率位居女性常见恶性肿瘤第2位,全球最常见恶性肿瘤第5位。超过35%的宫颈癌诊断时已达局部晚期,即Ⅰb2~Ⅱb期,5年总生存率约为60%。在欧洲、亚洲及拉丁美洲一些国家,新辅助化疗联合根治性手术已成为一线治疗方案。新辅助化疗作为一项新的治疗方法,其具体治疗方案、适应证及疗效评价仍需进一步研究。本文将针对局部晚期宫颈癌新辅助化疗的目的、方案、适应证、疗效等方面进行综述。 |
英文摘要: |
Abstract:Cervical cancer is the second most common cancer in women,the fifth most common malignancy in the world. It is estimated that over 35% of tumors are at locally advanced stage(stageⅠb2~Ⅱb) when diagnosed with an estimated 5-year overall survival of 60%.Neoadjuvant chemotherapy combined with radical surgery is the first line treatment in some countries of Europe,Asia and Latin America.Neoadjuvant chemotherapy as a new treatment,the specific procedure,indications and therapeutic evaluation needs to be studied further. This article summarizes from the principle,methods,indications,efficacy of neoadjuvant chemotherapy in the treatment for locally advanced cervical cancer. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |